These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31348785)

  • 41. Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.
    Sommavilla R; Pasche N; Trachsel E; Giovannoni L; Roesli C; Villa A; Neri D; Kaspar M
    Protein Eng Des Sel; 2010 Aug; 23(8):653-61. PubMed ID: 20551083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis.
    Hemmerle T; Doll F; Neri D
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12008-12. PubMed ID: 25092334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antitumor efficacy of the recombinant Newcastle disease virus rNDV-IL15 on melanoma models].
    Niu ZS; Bai FL; Sun T; Tian H; Yin JC; Cao HW; Yu D; Tian GY; Wu YZ; Li DS; Ren GP
    Yao Xue Xue Bao; 2014 Mar; 49(3):310-5. PubMed ID: 24961100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential protective role of IL15Rα during inflammation.
    Pan W; Wu X; Kastin AJ; Zhang Y; Hsuchou H; Halberg F; Chatu F; Khan RS; Robert B; Cornelissen-Guillaume GG
    J Mol Neurosci; 2011 Mar; 43(3):412-23. PubMed ID: 20981579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15
    Borrelli C; Ricci B; Vulpis E; Fionda C; Ricciardi MR; Petrucci MT; Masuelli L; Peri A; Cippitelli M; Zingoni A; Santoni A; Soriani A
    Cancer Immunol Res; 2018 Jul; 6(7):860-869. PubMed ID: 29691234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis.
    Yang Y; Zhang XM; Zhang N; Cheng L; Li C; Zhang S; Zhang JF; Dai L; Tian HW; Yan N; Fan P; Dai LX; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX
    Cancer Gene Ther; 2012 Jul; 19(7):460-7. PubMed ID: 22539063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of PDI overexpression on recombinant protein secretion in CHO cells.
    Davis R; Schooley K; Rasmussen B; Thomas J; Reddy P
    Biotechnol Prog; 2000; 16(5):736-43. PubMed ID: 11027164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The combination of NK and CD8+T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells.
    Ye JF; Qi WX; Liu MY; Li Y
    Cell Immunol; 2017 Aug; 318():35-41. PubMed ID: 28651743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of mouse B7-H3-Fc fusion protein and characterization of its bioactivity].
    Yan RH; Zhang GB; Sun J; Fu FQ; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1067-9. PubMed ID: 21055342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.
    Krenciute G; Prinzing BL; Yi Z; Wu MF; Liu H; Dotti G; Balyasnikova IV; Gottschalk S
    Cancer Immunol Res; 2017 Jul; 5(7):571-581. PubMed ID: 28550091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.
    Hemmerle T; Neri D
    Cancer Immunol Res; 2014 Jun; 2(6):559-67. PubMed ID: 24795141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation.
    Hemmerle T; Zgraggen S; Matasci M; Halin C; Detmar M; Neri D
    J Dermatol Sci; 2014 Nov; 76(2):96-103. PubMed ID: 25190364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cleavage-resistant fusion proteins of the M(2) muscarinic receptor and Gα(i1). Homotropic and heterotropic effects in the binding of ligands.
    Ma AW; Dong JY; Ma D; Wells JW
    Biochim Biophys Acta; 2011 Jun; 1810(6):592-602. PubMed ID: 21397664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion.
    Ng SSM; Nagy BA; Jensen SM; Hu X; Alicea C; Fox BA; Felber BK; Bergamaschi C; Pavlakis GN
    Clin Cancer Res; 2017 Jun; 23(11):2817-2830. PubMed ID: 27986749
    [No Abstract]   [Full Text] [Related]  

  • 56. Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15R
    Chen J; Shen Z; Jiang X; Huang Z; Wu C; Jiang D; Yin L
    Antib Ther; 2023 Jan; 6(1):38-48. PubMed ID: 36683766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.
    Manabe R; Ohe N; Maeda T; Fukuda T; Sekiguchi K
    J Cell Biol; 1997 Oct; 139(1):295-307. PubMed ID: 9314547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice.
    Chen T; Zhang Y; Wang Z; Yang J; Li M; Wang K; Cui M; Fu ZF; Zhao L; Zhou M
    Virol Sin; 2017 Aug; 32(4):317-327. PubMed ID: 28861771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4
    Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang X; Zhu M; Li Z; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
    Stem Cells Dev; 2018 Sep; 27(17):1203-1214. PubMed ID: 29901436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.